Skip to main content

Table 1 Baseline participants’ characteristics in a subcohort of the PREDIMED-Reus trial by tertiles of energy-adjusted nut consumption at baseline

From: Nut consumption is associated with a shift of the NMR lipoprotein subfraction profile to a less atherogenic pattern among older individuals at high CVD risk

 

Tertile 1

Tertile 2

Tertile 3

P-value

N

66

65

65

 

Total nuts, g/d

3.1 ± 2.9

8.5 ± 3.7

29.7 ± 15.3

 < 0.001

Walnuts, g/d

1.6 ± 2.1

4.3 ± 2.3

13.6 ± 9.4

 < 0.001

Non-walnut nuts, g/d

1.5 ± 1.6

4.2 ± 3.3

16.1 ± 11.4

 < 0.001

Women, %

52

66

54

0.192

Age, y

66 ± 7

67 ± 6

68 ± 5

0.091

 Allocation arm, %

   

0.154

 MedDiet + EVOO

13

10

15

 

MedDiet + nuts

11

11

11

 

Hypertension, %

97

97

92

0.344

Smoking status, %

   

0.445

 Never

56

68

62

 

 Current

20

14

15

 

Dyslipidemia, %

76

85

85

0.318

Education, %

   

0.822

  ≥ Secondary

20

23

15

 

Waist circumference, cm

100 ± 9

101 ± 9

100 ± 9

0.801

BMI, kg/m2

29.4 ± 3.4

29.9 ± 3.4

29.2 ± 3.3

0.463

Leisure time physical activity, MET-min/day

243.1 ± 238.0

270.0 ± 208.3

277.5 ± 277.3

0.696

Total energy intake, kcal/day

2480 ± 530

2137 ± 477

2426 ± 571

0.001

Glucose, mg/dL

93.0 ± 11.5

90.5 ± 8.9

92.4 ± 12.4

0.403

Triglycerides, mg/dL

138.7 ± 56.2

121.6 ± 53.4

123.8 ± 45.7

0.126

Total cholesterol, mg/dL

224.5 ± 33.6

223.6 ± 36.3

225.9 ± 32.1

0.931

HDL cholesterol, mg/dL

55.7 ± 13.0

60.6 ± 15.4

59.8 ± 12.7

0.097

LDL cholesterol, mg/dL

141.8 ± 28.7

140.6 ± 30.5

142.3 ± 29.3

0.946

  1. Data are means ± SDs unless otherwise stated